Privia Health Group, Inc. (PRVA)
NASDAQ: PRVA · Real-Time Price · USD
21.86
+0.10 (0.46%)
Aug 14, 2026, 10:30 AM EDT - Market open
Privia Health Group Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2,792 | 2,931 | 2,352 | 2,723 | 2,605 | 2,790 | |
Market Cap Growth | 9.86% | 24.60% | -13.61% | 4.53% | -6.64% | - |
Enterprise Value | 2,389 | 2,514 | 1,915 | 2,387 | 2,288 | 2,539 |
Last Close Price | 21.86 | 23.71 | 19.55 | 23.03 | 22.71 | 25.87 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 99.23 | 131.72 | 177.73 | 121.21 | - | - |
Forward PE | 57.49 | 91.72 | 80.52 | 93.73 | 215.10 | 130.98 |
PEG Ratio | - | 1.63 | - | - | - | - |
PS Ratio | 1.18 | 1.38 | 1.35 | 1.64 | 1.92 | 2.89 |
PB Ratio | 3.51 | 3.98 | 3.70 | 4.85 | 5.22 | 6.54 |
P/TBV Ratio | 8.20 | 9.81 | 6.40 | 9.11 | 7.99 | 11.14 |
P/FCF Ratio | 21.20 | 17.94 | 21.52 | 33.70 | 55.19 | 51.18 |
P/OCF Ratio | 21.20 | 17.94 | 21.52 | 33.70 | 55.19 | 50.67 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.01 | 1.18 | 1.10 | 1.44 | 1.69 | 2.63 |
EV/EBITDA Ratio | 41.73 | 56.96 | 78.96 | 87.83 | - | - |
EV/EBIT Ratio | 52.95 | 73.44 | 112.75 | 115.61 | - | - |
EV/FCF Ratio | 18.12 | 15.39 | 17.52 | 29.55 | 48.48 | 46.58 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.01 | 0.01 | 0.00 | 0.01 | 0.02 | 0.09 |
Debt / EBITDA Ratio | 0.15 | 0.22 | 0.23 | 0.31 | - | - |
Debt / FCF Ratio | 0.11 | 0.06 | 0.05 | 0.10 | 0.24 | 0.85 |
Net Debt / Equity Ratio | -0.52 | -0.64 | -0.76 | -0.68 | -0.67 | -0.64 |
Net Debt / EBITDA Ratio | -7.09 | -10.65 | -20.02 | -14.02 | 23.13 | 1.27 |
Net Debt / FCF Ratio | -4.94 | -2.88 | -4.44 | -4.72 | -7.13 | -5.03 |
Asset Turnover | 1.65 | 1.69 | 1.63 | 1.85 | 1.83 | 1.90 |
Quick Ratio | 1.55 | 1.55 | 1.80 | 1.76 | 2.03 | 2.30 |
Current Ratio | 1.62 | 1.60 | 1.86 | 1.81 | 2.09 | 2.35 |
Return on Equity (ROE) | 4.15% | 4.03% | 2.64% | 3.73% | -2.49% | -64.21% |
Return on Assets (ROA) | 1.89% | 1.85% | 0.97% | 1.67% | -1.68% | -37.37% |
Return on Invested Capital (ROIC) | 6.52% | 8.93% | 4.90% | 7.32% | -6.92% | -141.17% |
Return on Capital Employed (ROCE) | 5.42% | 4.60% | 2.61% | 3.62% | -3.73% | -64.15% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 1.01% | 0.76% | 0.56% | 0.83% | - | - |
FCF Yield | 4.72% | 5.58% | 4.65% | 2.97% | 1.81% | 1.95% |
Buyback Yield / Dilution | -2.73% | -2.61% | -0.74% | -12.64% | -7.52% | -7.30% |
Total Shareholder Return | -2.73% | -2.61% | -0.74% | -12.64% | -7.52% | -7.30% |